Incyte (INCY) Return on Equity [ROE] (2013 - 2026)
Incyte (INCY) posted Return on Equity [ROE] of 6.73% for Q3 2026, down 20.21 percentage points from 26.95% a year earlier and down 20.22 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025, Incyte's Return on Equity [ROE] came in at 29.87%, up 29.11 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +41.22 percentage points (FY2020 to FY2025).
- In prior years, Incyte's Return on Equity [ROE] was 0.76% in FY2024 (-11.75 pp), 12.50% in FY2023 (+4.13 pp), 8.37% in FY2022 (-21.36 pp) and 29.73% in FY2021 (+41.08 pp).
- The Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2025.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +7.14 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 39.25 percentage points; the weakest was Q3 2026, with a drop of 20.21 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 26.95% (Q2 2026), 26.54% (Q1 2026) and 26.21% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 6.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.73% |
| Jun 30, 2026 | 26.95% |
| Mar 31, 2026 | 26.54% |
| Dec 31, 2025 | 26.21% |
| Sep 30, 2025 | 26.95% |
| Jun 30, 2025 | 22.22% |
| Mar 31, 2025 | 0.60% |
| Dec 31, 2024 | 0.99% |
| Sep 30, 2024 | 1.05% |
| Jun 30, 2024 | 2.32% |
| Mar 31, 2024 | 14.09% |
| Dec 31, 2023 | 11.81% |
| Sep 30, 2023 | 8.79% |
| Jun 30, 2023 | 7.96% |
| Mar 31, 2023 | 7.34% |
| Dec 31, 2022 | 7.93% |
| Sep 30, 2022 | 21.08% |
| Jun 30, 2022 | 23.78% |
| Mar 31, 2022 | 24.45% |
| Dec 31, 2021 | 27.42% |
API Access
Incyte Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();